02.03.2013 Views

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

132 Matsumoto, Miyagishi, <strong>and</strong> Taira<br />

Fig. 1. Schematic of the mechanism of RNA interference.<br />

efficiently induce the cleavage of corresponding mRNAs (7). Since then, RNAi<br />

has received attention as a breakthrough technology for silencing specific genes<br />

in mammalian cells. However, the efficiency of transfection of synthesized<br />

siRNAs into human cells depends on cell types. Moreover, the RNAi effect<br />

seems to be sustained only for short time (8). To overcome this limitation, several<br />

groups have developed vectors encoding hairpin RNAs, leading to the<br />

expression of siRNA in cells <strong>and</strong> sustained gene silencing (9–14). Applications<br />

of RNAi-based screens were initially applied to Caenorhabditis elegans<br />

(15,16). Similarly, some recent articles highlight the potential of siRNA libraries<br />

for target discovery (17–34). We have screened siRNA library to identify components<br />

of the dsRNA-induced apoptotic pathway. The siRNA library contains<br />

700 vectors targeting 241 genes directly or indirectly involved in apoptosis.<br />

2. Materials<br />

2.1. Construction of siRNA Expression Vectors<br />

1. pcPUR hU6 vector (iGENE Therapeutic, Inc., Tsukuba, Japan, http://www.iGENEtherapeutics.co.jp).<br />

This plasmid contains the human U6 promoter <strong>and</strong> BspMI<br />

cloning sites (Fig. 2; [11]).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!